Currently, it is believed that Notch activation drives the lineage transition from ASCL1+ to NEUROD1+ to YAP1+ subtype59, whereas POU2F3 + SCLC is a standalone subtype that originated from tuft cells60. The gene discussed is ASCL1; the disease is small cell lung carcinoma.